Clinical Trial Update: Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports termination of the Phase 1/2 study of JI-101 in advanced low-grade endocrine tumors, ovarian cancer, and KRAS-mutant colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Neuroendocrine Tumor
• Ovarian Cancer

Drugs mentioned

• JI-101

Snippet

Sponsor: University of Utah | Conditions: Cancer, Neuroendocrine | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-09-25